Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But there’s still a long way to go to claw back the declines of the past ...

The market demand shows no sign of ebbing, and Novo Nordisk is putting its cash haul to work, striking deals to expand the company’s drug portfolio and pipeline. In a fireside chat Tuesday ...

Novo Nordisk is doubling down on its collaboration ... gave Novo three cardiovascular assets and set the stage for work on up to 11 programs overall. Novo was primarily focused on cardiovascular ...

Novo Nordisk said Wednesday it will sell Wegovy ... Studies like the one led by Barber, he said, don’t take into account the expensive work of research and development, or building the ...

COPENHAGEN, March 6 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab will ... But the class of drugs, which work by helping control blood sugar levels and triggering a feeling of fullness ...

According to the heat map I created, which distributes the winner by each parameter, Eli Lilly scored 7 points, while Novo Nordisk only 2. As a result, Eli Lilly is the winner in this category by ...

WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over unintended consequences. Illustration: Elizabeth Smelov Novo Nordisk’s big bet to improve on the success ...

Novo Nordisk. Construction work has begun and is expected to be completed in 2028. The investment is expected to create 600 permanent jobs upon completion of the facilities. During the ...